Photothermal MnO2 Nanoparticles Enhance Chemo-photothermal Therapy-induced Immunogenic Cell Death in Tumor Immunotherapy

Strategic Insights -

Researchers from Fujian Medical University in China have developed a new strategy for chemo-photothermal therapy-induced immunogenic cell death (ICD) in tumor immunotherapy. The team used photothermal MnO nanoparticles loaded with doxorubicin (DOX) to overcome the limitations of traditional ICD inducers and the immunosuppressive tumor microenvironment (TME). The nanoparticles achieved high photothermal conversion efficiency, efficient tumor targeting, and TME-responsive DOX release, resulting in a marked in vivo synergistic therapeutic effect in a triple-negative breast carcinoma-bearing mouse model.

Key Takeaways:

  • The research highlights the potential of modulating the TME with photothermal MnO nanosystems to enhance ICD-induced antitumor immunotherapy.
  • The photothermal MnO nanoparticles loaded with DOX achieved high photothermal conversion efficiency, efficient tumor targeting, and TME-responsive DOX release.
  • The nanoparticles demonstrated a marked in vivo synergistic therapeutic effect in a triple-negative breast carcinoma-bearing mouse model.
  • The research provides a new strategy for chemo-photothermal therapy-induced ICD in tumor immunotherapy.
  • The study may lead to the development of more effective treatments for cancer, particularly for triple-negative breast cancer.
  • The research was supported by the Natural Science Foundation of Fujian Province.
  • The study has been peer-reviewed and published in the International Journal of Pharmaceutics.

Statistics:

  • The photothermal MnO nanoparticles achieved a photothermal conversion efficiency of [no specific data provided].
  • The nanoparticles showed efficient tumor targeting and TME-responsive DOX release.
  • The in vivo synergistic therapeutic effect was achieved in a triple-negative breast carcinoma-bearing mouse model.
  • The study has been peer-reviewed and published in the International Journal of Pharmaceutics.

Sources:

  • International Journal of Pharmaceutics, "Photothermal MnO2 Nanoparticles Boost Chemo-photothermal Therapy-induced Immunogenic Cell Death in Tumor Immunotherapy" (2022; 617: 121578)
  • NewsRx, "Fujian Medical University Reports Findings in Nanoparticles" (2022; March 7)
  • Fujian Medical University, Qian Zhang (corresponding author)
  • International Journal of Pharmaceutics, Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands
  • NewsRx LLC, Copyright 2022.